Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review.

by Christiana Smith, Jeri E Forster, Myron J Levin, Jill Davies, Jennifer Pappas, Kay Kinzie, Emily Barr, Suzanne Paul, Elizabeth J McFarland, Adriana Weinberg
Published 2015-01-01

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

by Christiana Smith, Adriana Weinberg, Jeri E. Forster, Myron J. Levin, Jill Davies, Jennifer Pappas, Kay Kinzie, Emily Barr, Suzanne Paul, Elizabeth J. McFarland
Published 2016-01-01

Safety and Tolerability of Antiretrovirals during Pregnancy

by Adriana Weinberg, Jeri Forster-Harwood, Jill Davies, Elizabeth J. McFarland, Jennifer Pappas, Kay Kinzie, Emily Barr, Suzanne Paul, Carol Salbenblatt, Elizabeth Soda, Anna Vazquez, Myron J. Levin
Published 2011-01-01

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy

by Adriana Weinberg, Jeri E. F. Harwood, Elizabeth J. McFarland, Jennifer Pappas, Jill Davies, Kay Kinzie, Emily Barr, Suzanne Paul, Carol Salbenblatt, Elizabeth Soda, Anna Vazquez, Charles A. Peloquin, Myron J. Levin
Published 2009-01-01